Gallstones (Cholelithiasis)_ Practice Essentials, Background, Pathophysiology

  • Upload
    mmmm

  • View
    8

  • Download
    0

Embed Size (px)

DESCRIPTION

copied by http://emedicine.medscape.com

Citation preview

  • 10/13/2015 Gallstones(Cholelithiasis):PracticeEssentials,Background,Pathophysiology

    http://emedicine.medscape.com/article/175667overview 1/8

    Gallstones(Cholelithiasis)Author:DouglasMHeuman,MD,FACP,FACG,AGAFChiefEditor:JulianKatz,MDmore...

    Updated:Jan20,2015

    PracticeEssentialsCholelithiasisinvolvesthepresenceofgallstones(seetheimagebelow),whichareconcretionsthatforminthebiliarytract,usuallyinthegallbladder.Choledocholithiasisreferstothepresenceof1ormoregallstonesinthecommonbileduct(CBD).Treatmentofgallstonesdependsonthestageofdisease.

    Magneticresonancecholangiopancreatography(MRCP)showing5gallstonesinthecommonbileduct(arrows).Inthisimage,bileintheductappearswhitestonesappearasdarkfillingdefects.Similarimagescanbeobtainedbytakingplainradiographsafterinjectionofradiocontrastmaterialinthecommonbileduct,eitherendoscopically(endoscopicretrogradecholangiography)orpercutaneouslyunderfluoroscopicguidance(percutaneoustranshepaticcholangiography),buttheseapproachesaremoreinvasive.

    Signsandsymptoms

    Gallstonediseasemaybethoughtofashavingthefollowing4stages:

    1. Lithogenicstate,inwhichconditionsfavorgallstoneformation2. Asymptomaticgallstones3. Symptomaticgallstones,characterizedbyepisodesofbiliarycolic4. Complicatedcholelithiasis

    SymptomsandcomplicationsresultfromeffectsoccurringwithinthegallbladderorfromstonesthatescapethegallbladdertolodgeintheCBD.

    Characteristicsofbiliarycolicincludethefollowing:

    SporadicandunpredictableepisodesPainthatislocalizedtotheepigastriumorrightupperquadrant,sometimesradiatingtotherightscapulartipPainthatbeginspostprandially,isoftendescribedasintenseanddull,typicallylasts15hours,increasessteadilyover1020minutes,andthengraduallywanesPainthatisconstantnotrelievedbyemesis,antacids,defecation,flatus,orpositionalchangesandsometimesaccompaniedbydiaphoresis,nausea,andvomitingNonspecificsymptoms(eg,indigestion,dyspepsia,belching,orbloating)

    Patientswiththelithogenicstateorasymptomaticgallstoneshavenoabnormalfindingsonphysicalexamination.

    Distinguishinguncomplicatedbiliarycolicfromacutecholecystitisorothercomplicationsisimportant.Keyfindingsthatmaybenotedincludethefollowing:

    UncomplicatedbiliarycolicPainthatispoorlylocalizedandvisceralanessentiallybenignabdominalexaminationwithoutreboundorguardingabsenceoffeverAcutecholecystitisWelllocalizedpainintherightupperquadrant,usuallywithreboundandguardingpositiveMurphysign(nonspecific)frequentpresenceoffeverabsenceofperitonealsignsfrequentpresenceoftachycardiaanddiaphoresisinseverecases,absentorhypoactivebowelsounds

    Thepresenceoffever,persistenttachycardia,hypotension,orjaundicenecessitatesasearchforcomplications,whichmayincludethefollowing:

    CholecystitisCholangitisPancreatitisOthersystemiccauses

    SeePresentationformoredetail.

    Diagnosis

  • 10/13/2015 Gallstones(Cholelithiasis):PracticeEssentials,Background,Pathophysiology

    http://emedicine.medscape.com/article/175667overview 2/8

    Patientswithuncomplicatedcholelithiasisorsimplebiliarycolictypicallyhavenormallaboratorytestresultslaboratorystudiesaregenerallynotnecessaryunlesscomplicationsaresuspected.Bloodtests,whenindicated,mayincludethefollowing:

    Completebloodcount(CBC)withdifferentialLiverfunctionpanelAmylaseLipase

    Imagingmodalitiesthatmaybeusefulincludethefollowing:

    Abdominalradiography(uprightandsupine)Usedprimarilytoexcludeothercausesofabdominalpain(eg,intestinalobstruction)UltrasonographyTheprocedureofchoiceinsuspectedgallbladderorbiliarydiseaseEndoscopicultrasonography(EUS)AnaccurateandrelativelynoninvasivemeansofidentifyingstonesinthedistalCBDLaparoscopicultrasonographyPromisingasapotentialmethodforbileductimagingduringlaparoscopiccholecystectomyComputedtomography(CT)Moreexpensiveandlesssensitivethanultrasonographyfordetectinggallbladderstones,butsuperiorfordemonstratingstonesinthedistalCBDMagneticresonanceimaging(MRI)withmagneticresonancecholangiopancreatography(MRCP)UsuallyreservedforcasesinwhichcholedocholithiasisissuspectedScintigraphyHighlyaccurateforthediagnosisofcysticductobstructionEndoscopicretrogradecholangiopancreatography(ERCP)Percutaneoustranshepaticcholangiography(PTC)

    SeeWorkupformoredetail.

    Management

    Thetreatmentofgallstonesdependsuponthestageofdisease,asfollows:

    LithogenicstateInterventionsarecurrentlylimitedtoafewspecialcircumstancesAsymptomaticgallstonesExpectantmanagementSymptomaticgallstonesUsually,definitivesurgicalintervention(eg,cholecystectomy),thoughmedicaldissolutionmaybeconsideredinsomecases

    Medicaltreatments,usedindividuallyorincombination,includethefollowing:

    Oralbilesalttherapy(ursodeoxycholicacid)ContactdissolutionExtracorporealshockwavelithotripsy

    Cholecystectomyforasymptomaticgallstonesmaybeindicatedinthefollowingpatients:

    Thosewithlarge(>2cm)gallstonesThosewhohaveanonfunctionalorcalcified(porcelain)gallbladderonimagingstudiesandwhoareathighriskofgallbladdercarcinomaThosewithspinalcordinjuriesorsensoryneuropathiesaffectingtheabdomenThosewithsicklecellanemiainwhomthedistinctionbetweenpainfulcrisisandcholecystitismaybedifficult

    Patientswiththefollowingriskfactorsforcomplicationsofgallstonesmaybeofferedelectivecholecystectomy,eveniftheyhaveasymptomaticgallstones:

    CirrhosisPortalhypertensionChildrenTransplantcandidatesDiabeteswithminorsymptoms

    Surgicalinterventionstobeconsideredincludethefollowing:

    Cholecystectomy(openorlaparoscopic)CholecystostomyEndoscopicsphincterotomy

    SeeTreatmentandMedicationformoredetail.

    BackgroundCholelithiasisisthemedicaltermforgallstonedisease.Gallstonesareconcretionsthatforminthebiliarytract,usuallyinthegallbladder(seetheimagebelow).

  • 10/13/2015 Gallstones(Cholelithiasis):PracticeEssentials,Background,Pathophysiology

    http://emedicine.medscape.com/article/175667overview 3/8

    Excisedgallbladderopenedtoshow3gallstones

    Gallstonesdevelopinsidiously,andtheymayremainasymptomaticfordecades.Migrationofaagallstoneintotheopeningofthecysticductmayblocktheoutflowofbileduringgallbladdercontraction.Theresultingincreaseingallbladderwalltensionproducesacharacteristictypeofpain(biliarycolic).Cysticductobstruction,ifitpersistsformorethanafewhours,mayleadtoacutegallbladderinflammation(acutecholecystitis).

    Choledocholithiasisreferstothepresenceofoneormoregallstonesinthecommonbileduct.Usually,thisoccurswhenagallstonepassesfromthegallbladderintothecommonbileduct(seetheimagebelow).

    Commonbileductstone(choledocholithiasis).Thesensitivityoftransabdominalultrasonographyforcholedocholithiasisisapproximately75%inthepresenceofdilatedductsand50%fornondilatedducts.ImagecourtesyofDTSchwartz.

    AgallstoneinthecommonbileductmayimpactdistallyintheampullaofVater,thepointwherethecommonbileductandpancreaticductjoinbeforeopeningintotheduodenum.Obstructionofbileflowbyastoneatthiscriticalpointmayleadtoabdominalpainandjaundice.Stagnantbileaboveanobstructingbileductstoneoftenbecomesinfected,andbacteriacanspreadrapidlybackuptheductalsystemintothelivertoproducealifethreateninginfectioncalledascendingcholangitis.ObstructionofthepancreaticductbyagallstoneintheampullaofVateralsocantriggeractivationofpancreaticdigestiveenzymeswithinthepancreasitself,leadingtoacutepancreatitis.[1,2]

    Chronically,gallstonesinthegallbladdermaycauseprogressivefibrosisandlossoffunctionofthegallbladder,aconditionknownaschroniccholecystitis.Chroniccholecystitispredisposestogallbladdercancer.

    Ultrasonographyistheinitialdiagnosticprocedureofchoiceinmostcasesofsuspectedgallbladderorbiliarytractdisease(seeWorkup).

    Thetreatmentofgallstonesdependsuponthestageofdisease.Asymptomaticgallstonesmaybemanagedexpectantly.Oncegallstonesbecomesymptomatic,definitivesurgicalinterventionwithexcisionofthegallbladder(cholecystectomy)isusuallyindicated.Cholecystectomyisamongthemostfrequentlyperformedabdominalsurgicalprocedures(seeTreatment).Complicationsofgallstonediseasemayrequirespecializedmanagementtorelieveobstructionandinfection.

    GotoPediatricCholelithiasisforcompleteinformationonthistopic.

    PathophysiologyGallstoneformationoccursbecausecertainsubstancesinbilearepresentinconcentrationsthatapproachthelimitsoftheirsolubility.Whenbileisconcentratedinthegallbladder,itcanbecomesupersaturatedwiththesesubstances,whichthenprecipitatefromsolutionasmicroscopiccrystals.Thecrystalsaretrappedingallbladdermucus,producinggallbladdersludge.Overtime,thecrystalsgrow,aggregate,andfusetoformmacroscopicstones.Occlusionoftheductsbysludgeand/orstonesproducesthecomplicationsofgallstonedisease.

    The2mainsubstancesinvolvedingallstoneformationarecholesterolandcalciumbilirubinate.

    Cholesterolgallstones

    Morethan80%ofgallstonesintheUnitedStatescontaincholesterolastheirmajorcomponent.Livercellssecretecholesterolintobilealongwithphospholipid(lecithin)

  • 10/13/2015 Gallstones(Cholelithiasis):PracticeEssentials,Background,Pathophysiology

    http://emedicine.medscape.com/article/175667overview 4/8

    intheformofsmallsphericalmembranousbubbles,termedunilamellarvesicles.Livercellsalsosecretebilesalts,whicharepowerfuldetergentsrequiredfordigestionandabsorptionofdietaryfats.

    Bilesaltsinbiledissolvetheunilamellarvesiclestoformsolubleaggregatescalledmixedmicelles.Thishappensmainlyinthegallbladder,wherebileisconcentratedbyreabsorptionofelectrolytesandwater.

    Comparedwithvesicles(whichcanholdupto1moleculeofcholesterolforeverymoleculeoflecithin),mixedmicelleshavealowercarryingcapacityforcholesterol(about1moleculeofcholesterolforevery3moleculesoflecithin).Ifbilecontainsarelativelyhighproportionofcholesteroltobeginwith,thenasbileisconcentrated,progressivedissolutionofvesiclesmayleadtoastateinwhichthecholesterolcarryingcapacityofthemicellesandresidualvesiclesisexceeded.Atthispoint,bileissupersaturatedwithcholesterol,andcholesterolmonohydratecrystalsmayform.

    Thus,themainfactorsthatdeterminewhethercholesterolgallstoneswillformare(1)theamountofcholesterolsecretedbylivercells,relativetolecithinandbilesalts,and(2)thedegreeofconcentrationandextentofstasisofbileinthegallbladder.

    Calcium,bilirubin,andpigmentgallstones

    Bilirubin,ayellowpigmentderivedfromthebreakdownofheme,isactivelysecretedintobilebylivercells.Mostofthebilirubininbileisintheformofglucuronideconjugates,whicharequitewatersolubleandstable,butasmallproportionconsistsofunconjugatedbilirubin.Unconjugatedbilirubin,likefattyacids,phosphate,carbonate,andotheranions,tendstoforminsolubleprecipitateswithcalcium.Calciumentersbilepassivelyalongwithotherelectrolytes.

    Insituationsofhighhemeturnover,suchaschronichemolysisorcirrhosis,unconjugatedbilirubinmaybepresentinbileathigherthannormalconcentrations.Calciumbilirubinatemaythencrystallizefromsolutionandeventuallyformstones.Overtime,variousoxidationscausethebilirubinprecipitatestotakeonajetblackcolor,andstonesformedinthismanneraretermedblackpigmentgallstones.Blackpigmentstonesrepresent1020%ofgallstonesintheUnitedStates.

    Bileisnormallysterile,butinsomeunusualcircumstances(eg,aboveabiliarystricture),itmaybecomecolonizedwithbacteria.Thebacteriahydrolyzeconjugatedbilirubin,andtheresultingincreaseinunconjugatedbilirubinmayleadtoprecipitationofcalciumbilirubinatecrystals.

    Bacteriaalsohydrolyzelecithintoreleasefattyacids,whichalsomaybindcalciumandprecipitatefromsolution.Theresultingconcretionshaveaclaylikeconsistencyandaretermedbrownpigmentstones.Unlikecholesterolorblackpigmentgallstones,whichformalmostexclusivelyinthegallbladder,brownpigmentgallstonesoftenformdenovointhebileducts.BrownpigmentgallstonesareunusualintheUnitedStatesbutarefairlycommoninsomepartsofSoutheastAsia,possiblyrelatedtoliverflukeinfestation.

    Mixedgallstones

    Cholesterolgallstonesmaybecomecolonizedwithbacteriaandcanelicitgallbladdermucosalinflammation.Lyticenzymesfrombacteriaandleukocyteshydrolyzebilirubinconjugatesandfattyacids.Asaresult,overtime,cholesterolstonesmayaccumulateasubstantialproportionofcalciumbilirubinateandothercalciumsalts,producingmixedgallstones.Largestonesmaydevelopasurfacerimofcalciumresemblinganeggshellthatmaybevisibleonplainxrayfilms.

    EtiologyCholesterolgallstones,blackpigmentgallstones,andbrownpigmentgallstoneshavedifferentpathogenesesanddifferentriskfactors.

    Cholesterolgallstones

    Cholesterolgallstonesareassociatedwithfemalesex,EuropeanorNativeAmericanancestry,andincreasingage.Otherriskfactorsincludethefollowing:

    ObesityPregnancyGallbladderstasisDrugsHeredity

    Themetabolicsyndromeoftruncalobesity,insulinresistance,typeIIdiabetesmellitus,hypertension,andhyperlipidemiaisassociatedwithincreasedhepaticcholesterolsecretionandisamajorriskfactorforthedevelopmentofcholesterolgallstones.

    Cholesterolgallstonesaremorecommoninwomenwhohaveexperiencedmultiplepregnancies.Amajorcontributingfactoristhoughttobethehighprogesteronelevelsofpregnancy.Progesteronereducesgallbladdercontractility,leadingtoprolongedretentionandgreaterconcentrationofbileinthegallbladder.

    Othercausesofgallbladderstasisassociatedwithincreasedriskofgallstonesincludehighspinalcordinjuries,prolongedfastingwithtotalparenteralnutrition,andrapidweightlossassociatedwithseverecaloricandfatrestriction(eg,diet,gastricbypasssurgery).

    Anumberofmedicationsareassociatedwithformationofcholesterolgallstones.Estrogensadministeredforcontraceptionorfortreatmentofprostatecancerincreasetheriskofcholesterolgallstonesbyincreasingbiliarycholesterolsecretion.Clofibrateandotherfibratehypolipidemicdrugsincreasehepaticeliminationofcholesterolviabiliarysecretionandappeartoincreasetheriskofcholesterolgallstones.Somatostatinanaloguesappeartopredisposetogallstonesby

  • 10/13/2015 Gallstones(Cholelithiasis):PracticeEssentials,Background,Pathophysiology

    http://emedicine.medscape.com/article/175667overview 5/8

    decreasinggallbladderemptying.

    About25%ofthepredispositiontocholesterolgallstonesappearstobehereditary,asjudgedfromstudiesofidenticalandfraternaltwins.Atleastadozengenesmaycontributetotherisk.[3]Araresyndromeoflowphospholipidassociatedcholelithiasisoccursinindividualswithahereditarydeficiencyofthebiliarytransportproteinrequiredforlecithinsecretion.[4]

    Blackandbrownpigmentgallstones

    Blackpigmentgallstonesoccurdisproportionatelyinindividualswithhighhemeturnover.Disordersofhemolysisassociatedwithpigmentgallstonesincludesicklecellanemia,hereditaryspherocytosis,andbetathalassemia.Incirrhosis,portalhypertensionleadstosplenomegaly.This,inturn,causesredcellsequestration,leadingtoamodestincreaseinhemoglobinturnover.Abouthalfofallcirrhoticpatientshavepigmentgallstones.

    Prerequisitesforformationofbrownpigmentgallstonesincludeintraductalstasisandchroniccolonizationofbilewithbacteria.IntheUnitedStates,thiscombinationismostoftenencounteredinpatientswithpostsurgicalbiliarystricturesorcholedochalcysts.

    InricegrowingregionsofEastAsia,infestationwithbiliaryflukesmayproducebiliarystricturesandpredisposetoformationofbrownpigmentstonesthroughoutintrahepaticandextrahepaticbileducts.Thiscondition,termedhepatolithiasis,causesrecurrentcholangitisandpredisposestobiliarycirrhosisandcholangiocarcinoma.

    Othercomorbidities

    Crohndisease,ilealresection,orotherdiseasesoftheileumdecreasebilesaltreabsorptionandincreasetheriskofgallstoneformation.

    Otherillnessesorstatesthatpredisposetogallstoneformationincludeburns,useoftotalparenteralnutrition,paralysis,ICUcare,andmajortrauma.Thisisdue,ingeneral,todecreasedenteralstimulationofthegallbladderwithresultantbiliarystasisandstoneformation.

    EpidemiologyTheprevalenceofcholelithiasisisaffectedbymanyfactors,includingethnicity,gender,comorbidities,andgenetics.

    UnitedStatesstatistics

    IntheUnitedStates,about20millionpeople(1020%ofadults)havegallstones.Everyyear13%ofpeopledevelopgallstonesandabout13%ofpeoplebecomesymptomatic.Eachyear,intheUnitedStates,approximately500,000peopledevelopsymptomsorcomplicationsofgallstonesrequiringcholecystectomy.

    Gallstonediseaseisresponsibleforabout10,000deathsperyearintheUnitedStates.About7000deathsareattributabletoacutegallstonecomplications,suchasacutepancreatitis.About20003000deathsarecausedbygallbladdercancers(80%ofwhichoccurinthesettingofgallstonediseasewithchroniccholecystitis).Althoughgallstonesurgeryisrelativelysafe,cholecystectomyisaverycommonprocedure,anditsrarecomplicationsresultinseveralhundreddeathseachyear.

    Internationalstatistics

    TheprevalenceofcholesterolcholelithiasisinotherWesternculturesissimilartothatintheUnitedStates,butitappearstobesomewhatlowerinAsiaandAfrica.

    ASwedishepidemiologicstudyfoundthattheincidenceofgallstoneswas1.39per100personyears.[5]InanItalianstudy,20%ofwomenhadstones,and14%ofmenhadstones.InaDanishstudy,gallstoneprevalenceinpersonsaged30yearswas1.8%formenand4.8%forwomengallstoneprevalenceinpersonsaged60yearswas12.9%formenand22.4%forwomen.

    TheprevalenceofcholedocholithiasisishigherinternationallythanintheUnitedStates,mainlybecauseoftheadditionalproblemofprimarycommonbileductstonescausedbyparasiticinfestationwithliverflukessuchasClonorchissinensis.

    Race,sex,andagerelateddemographics

    PrevalenceofgallstonesishighestinpeopleofnorthernEuropeandescent,andinHispanicpopulationsandNativeAmericanpopulations.[6]PrevalenceofgallstonesislowerinAsiansandAfricanAmericans.

    Womenaremorelikelytodevelopcholesterolgallstonesthanmen,especiallyduringtheirreproductiveyears,whentheincidenceofgallstonesinwomenis23timesthatinmen.Thedifferenceappearstobeattributablemainlytoestrogen,whichincreasesbiliarycholesterolsecretion.[7]

    Riskofdevelopinggallstonesincreaseswithage.Gallstonesareuncommoninchildrenintheabsenceofcongenitalanomaliesorhemolyticdisorders.Beginningatpuberty,theconcentrationofcholesterolinbileincreases.Afterage15years,theprevalenceofgallstonesinUSwomenincreasesbyabout1%peryearinmen,therateisless,about0.5%peryear.Gallstonescontinuetoformthroughoutadultlife,andtheprevalenceisgreatestatadvancedage.Theincidenceinwomenfallswithmenopause,butnewstoneformationinmenandwomencontinuesatarateofabout0.4%peryearuntillateinlife.

    Amongindividualsundergoingcholecystectomyforsymptomaticcholelithiasis,815%ofpatientsyoungerthan60yearshavecommonbileductstones,comparedwith1560%ofpatientsolderthan60years.

  • 10/13/2015 Gallstones(Cholelithiasis):PracticeEssentials,Background,Pathophysiology

    http://emedicine.medscape.com/article/175667overview 6/8

    PrognosisLessthanhalfofpatientswithgallstonesbecomesymptomatic.Themortalityrateforanelectivecholecystectomyis0.5%withlessthan10%morbidity.Themortalityrateforanemergentcholecystectomyis35%with3050%morbidity.

    Followingcholecystectomy,stonesmayrecurinthebileduct.

    Approximately1015%ofpatientshaveanassociatedcholedocholithiasis.Theprognosisinpatientswithcholedocholithiasisdependsonthepresenceandseverityofcomplications.Ofallpatientswhorefusesurgeryorareunfittoundergosurgery,45%remainasymptomaticfromcholedocholithiasis,while55%experiencevaryingdegreesofcomplications.

    PatientEducationPatientswithasymptomaticgallstonesshouldbeeducatedtorecognizeandreportthesymptomsofbiliarycolicandacutepancreatitis.Alarmsymptomsincludepersistentepigastricpainlastingforgreaterthan20minutes,especiallyifaccompaniedbynausea,vomiting,orfever.Ifpainissevereorpersistsformorethananhour,thepatientshouldseekimmediatemedicalattention.

    Forpatienteducationinformation,seetheLiver,Gallbladder,andPancreasCenterandCholesterolCenter,aswellasGallstones.

    ClinicalPresentation

    ContributorInformationandDisclosuresAuthorDouglasMHeuman,MD,FACP,FACG,AGAFChiefofHepatology,HunterHolmesMcGuireDepartmentofVeteransAffairsMedicalCenterProfessor,DepartmentofInternalMedicine,DivisionofGastroenterology,VirginiaCommonwealthUniversitySchoolofMedicine

    DouglasMHeuman,MD,FACP,FACG,AGAFisamemberofthefollowingmedicalsocieties:AmericanAssociationfortheStudyofLiverDiseases,AmericanCollegeofPhysicians,AmericanGastroenterologicalAssociation

    Disclosure:Receivedgrant/researchfundsfromNovartisforotherReceivedgrant/researchfundsfromBayerforotherReceivedgrant/researchfundsfromOtsukafornoneReceivedgrant/researchfundsfromBristolMyersSquibbforotherReceivednonefromScynexisfornoneReceivedgrant/researchfundsfromSalixforotherReceivedgrant/researchfundsfromMannKindforother.

    Coauthor(s)JeffAllen,MDAssistantProfessor,DepartmentofSurgery,UniversityofLouisville

    Disclosure:Nothingtodisclose.

    AnastasiosAMihas,MD,DMSc,FACP,FACGProfessor,DepartmentofMedicine,DivisionofGastroenterology,VirginiaCommonwealthUniversitySchoolofMedicineConsultingStaff,VirginiaCommonwealthUniversityHospitalsandClinicsChiefofGIClinicalResearch,DirectorofGIOutpatientService,AssociateDirectorofHepatology,HunterHolmesMcGuireVeteransAffairsMedicalCenter

    AnastasiosAMihas,MD,DMSc,FACP,FACGisamemberofthefollowingmedicalsocieties:AmericanAssociationfortheStudyofLiverDiseases,AmericanCollegeofGastroenterology,AmericanCollegeofPhysicians,AmericanGastroenterologicalAssociation,AmericanSocietyforGastrointestinalEndoscopy,SigmaXi,SouthernSocietyforClinicalInvestigation,AmericanFederationforClinicalResearch,GastroenterologyResearchGroup

    Disclosure:Nothingtodisclose.

    ChiefEditorJulianKatz,MDClinicalProfessorofMedicine,DrexelUniversityCollegeofMedicine

    JulianKatz,MDisamemberofthefollowingmedicalsocieties:AmericanCollegeofGastroenterology,AmericanCollegeofPhysicians,AmericanGastroenterologicalAssociation,AmericanGeriatricsSociety,AmericanMedicalAssociation,AmericanSocietyforGastrointestinalEndoscopy,AmericanSocietyofLaw,Medicine&Ethics,AmericanTraumaSociety,AssociationofAmericanMedicalColleges,PhysiciansforSocialResponsibility

    Disclosure:Nothingtodisclose.

    AcknowledgementsFirassAbiad,MDHeadofDivision,GeneralandLaparoscopicSurgery,SpecializedMedicalCenterHospital,SaudiArabia

    Disclosure:Nothingtodisclose.

    BSAnand,MDProfessor,DepartmentofInternalMedicine,DivisionofGastroenterology,BaylorCollegeofMedicine

    BSAnand,MDisamemberofthefollowingmedicalsocieties:AmericanAssociationfortheStudyofLiverDiseases,AmericanCollegeofGastroenterology,AmericanGastroenterologicalAssociation,andAmericanSocietyforGastrointestinalEndoscopy

    Disclosure:Nothingtodisclose.

    DavidEricBernstein,MDDirectorofHepatology,NorthShoreUniversityHospitalProfessorofClinicalMedicine,AlbertEinsteinCollegeofMedicine

    DavidEricBernstein,MDisamemberofthefollowingmedicalsocieties:AmericanAssociationfortheStudyofLiverDiseases,AmericanCollegeofGastroenterology,AmericanCollegeofPhysicians,AmericanGastroenterologicalAssociation,andAmericanSocietyforGastrointestinalEndoscopy

    Disclosure:Nothingtodisclose.

    BarryEBrenner,MD,PhD,FACEPProfessorofEmergencyMedicine,ProfessorofInternalMedicine,

  • 10/13/2015 Gallstones(Cholelithiasis):PracticeEssentials,Background,Pathophysiology

    http://emedicine.medscape.com/article/175667overview 7/8

    ProgramDirector,EmergencyMedicine,CaseMedicalCenter,UniversityHospitals,CaseWesternReserveUniversitySchoolofMedicine

    BarryEBrenner,MD,PhD,FACEPisamemberofthefollowingmedicalsocieties:AlphaOmegaAlpha,AmericanAcademyofEmergencyMedicine,AmericanCollegeofChestPhysicians,AmericanCollegeofEmergencyPhysicians,AmericanCollegeofPhysicians,AmericanHeartAssociation,AmericanThoracicSociety,ArkansasMedicalSociety,NewYorkAcademyofMedicine,NewYorkAcademyofSciences,andSocietyforAcademicEmergencyMedicine

    Disclosure:Nothingtodisclose.

    DavidFMBrown,MDAssociateProfessor,DivisionofEmergencyMedicine,HarvardMedicalSchoolViceChair,DepartmentofEmergencyMedicine,MassachusettsGeneralHospital

    DavidFMBrown,MDisamemberofthefollowingmedicalsocieties:AmericanCollegeofEmergencyPhysiciansandSocietyforAcademicEmergencyMedicine

    Disclosure:Nothingtodisclose.

    WilliamKChiang,MDAssociateProfessor,DepartmentofEmergencyMedicine,NewYorkUniversitySchoolofMedicineChiefofService,DepartmentofEmergencyMedicine,BellevueHospitalCenter

    WilliamKChiang,MDisamemberofthefollowingmedicalsocieties:AmericanAcademyofClinicalToxicology,AmericanCollegeofMedicalToxicology,andSocietyforAcademicEmergencyMedicine

    Disclosure:Nothingtodisclose.

    AlfredCuschieri,MD,ChM,FRSE,FRCS,Head,Professor,DepartmentofSurgeryandMolecularOncology,UniversityofDundee,UK

    Disclosure:Nothingtodisclose.

    ImadSDandan,MDConsultingSurgeon,DepartmentofSurgery,TraumaSection,ScrippsMemorialHospital

    ImadSDandan,MDisamemberofthefollowingmedicalsocieties:AmericanAssociationfortheSurgeryofTrauma,AmericanCollegeofSurgeons,AmericanMedicalAssociation,AmericanTraumaSociety,CaliforniaMedicalAssociation,andSocietyofCriticalCareMedicine

    Disclosure:Nothingtodisclose.

    DavidGreenwald,MDAssociateProfessorofClinicalMedicine,FellowshipProgramDirector,DepartmentofMedicine,DivisionofGastroenterology,MontefioreMedicalCenter,AlbertEinsteinCollegeofMedicine

    DavidGreenwald,MDisamemberofthefollowingmedicalsocieties:AlphaOmegaAlpha,AmericanCollegeofGastroenterology,AmericanCollegeofPhysicians,AmericanGastroenterologicalAssociation,AmericanSocietyforGastrointestinalEndoscopy,andNewYorkSocietyforGastrointestinalEndoscopy

    Disclosure:Nothingtodisclose.

    EugeneHardin,MD,FAAEM,FACEPFormerChairandAssociateProfessor,DepartmentofEmergencyMedicine,CharlesDrewUniversityofMedicineandScienceFormerChair,DepartmentofEmergencyMedicine,MartinLutherKingJr/DrewMedicalCenter

    Disclosure:Nothingtodisclose.

    FayeMaryannLee,MDStaffPhysician,DepartmentofEmergencyMedicine,NewYorkUniversity/BellevueHospitalCenter

    FayeMaryannLee,MDisamemberofthefollowingmedicalsocieties:PhiBetaKappa

    Disclosure:Nothingtodisclose.

    SallySanten,MDProgramDirector,AssistantProfessor,DepartmentofEmergencyMedicine,VanderbiltUniversity

    SallySanten,MDisamemberofthefollowingmedicalsocieties:AmericanCollegeofEmergencyPhysiciansandSocietyforAcademicEmergencyMedicine

    Disclosure:Nothingtodisclose.

    AssaadMSoweid,MD,FASGE,FACGAssociateProfessorofClinicalMedicine,EndosonographyandAdvancedTherapeuticEndoscopy,Director,EndoscopyBronchoscopyUnit,DivisionofGastroenterology,DepartmentofInternalMedicine,AmericanUniversityofBeirutMedicalCenter,Lebanon

    AssaadMSoweid,MD,FASGE,FACGisamemberofthefollowingmedicalsocieties:AmericanCollegeofGastroenterology,AmericanCollegeofPhysicians,AmericanCollegeofPhysiciansAmericanSocietyofInternalMedicine,AmericanGynecologicalandObstetricalSociety,andAmericanMedicalAssociation

    Disclosure:Nothingtodisclose.

    FranciscoTalavera,PharmD,PhDAdjunctAssistantProfessor,UniversityofNebraskaMedicalCenterCollegeofPharmacyEditorinChief,MedscapeDrugReference

    Disclosure:MedscapeSalaryEmployment

    References

    1. HeumanDM,MooreEL,VlahcevicZR.Pathogenesisanddissolutionofgallstones.ZakimD,BoyerTD,eds.Hepatology:ATextbookofLiverDisease.3rded.Philadelphia,Pa:WBSaunders1996.1996:376417.

    2. CenterSA.Diseasesofthegallbladderandbiliarytree.VetClinNorthAmSmallAnimPract.2009May.39(3):54398.[Medline].

    3. PortincasaP,MoschettaA,PalascianoG.Cholesterolgallstonedisease.Lancet.2006Jul15.368(9531):2309.[Medline].

    4. PouponR,RosmorducO,BollePY,ChrtienY,CorpechotC,ChazouillresO,etal.Genotypephenotyperelationshipsinthelowphospholipidassociatedcholelithiasissyndrome.Astudyof156consecutivepatients.Hepatology.2013Mar26.[Medline].

  • 10/13/2015 Gallstones(Cholelithiasis):PracticeEssentials,Background,Pathophysiology

    http://emedicine.medscape.com/article/175667overview 8/8

    MedscapeReference2011WebMD,LLC

    5. HalldestamI,KullmanE,BorchK.Incidenceofandpotentialriskfactorsforgallstonediseaseinageneralpopulationsample.BrJSurg.2009Nov.96(11):131522.[Medline].

    6. ShafferEA.Epidemiologyandriskfactorsforgallstonedisease:hastheparadigmchangedinthe21stcentury?.CurrGastroenterolRep.2005May.7(2):13240.[Medline].

    7. WangHH,LiuM,CleggDJ,PortincasaP,WangDQ.Newinsightsintothemolecularmechanismsunderlyingeffectsofestrogenoncholesterolgallstoneformation.BiochimBiophysActa.2009Nov.1791(11):103747.[Medline].[FullText].

    8. GilaniSN,BassG,LeaderF,WalshTN.Collins'sign:validationofaclinicalsignincholelithiasis.IrJMedSci.2009Aug14.[Medline].

    9. ZaliekasJ,MunsonJL.Complicationsofgallstones:theMirizzisyndrome,gallstoneileus,gallstonepancreatitis,complicationsof"lost"gallstones.SurgClinNorthAm.2008Dec.88(6):134568,x.[Medline].

    10. DauerM,LammertF.Mandatoryandoptionalfunctiontestsforbiliarydisorders.BestPractResClinGastroenterol.2009.23(3):44151.[Medline].

    11. [Guideline]KatzDS,RosenMP,BlakeMA,etalandExpertPanelonGastrointestinalImaging.ACRAppropriatenessCriteriarightupperquadrantpain.[onlinepublication].Reston(VA):AmericanCollegeofRadiology(ACR).[FullText].

    12. ShapiroT,MelzerE,BinderY,KeterD,ZbarA,MillerR,etal.SelectiveUtilizationofPreOperativeEndoscopicUltrasoundtoExcludeCholedocholithiasisPriortoLaparoscopicCholecystectomy:ARetrospectiveStudy.Hepatogastroenterology.2013May1.60(123):[Medline].

    13. YaoCC,HuangSM,LinCC,HoLC,ChangSW,ChenHM,etal.Assessmentofcommonbileductusinglaparoscopicultrasoundduringlaparoscopiccholecystectomy.SurgLaparoscEndoscPercutanTech.2009Aug.19(4):31720.[Medline].

    14. MahidSS,JafriNS,BrangersBC,MinorKS,HornungCA,GalandiukS.Metaanalysisofcholecystectomyinsymptomaticpatientswithpositivehepatobiliaryiminodiaceticacidscanresultswithoutgallstones.ArchSurg.2009Feb.144(2):1807.[Medline].

    15. [Guideline]NIHstateofthesciencestatementonendoscopicretrogradecholangiopancreatography(ERCP)fordiagnosisandtherapy.NIHConsensStateSciStatements.2002Jan1416.19(1):126.[Medline].

    16. BinenbaumSJ,TeixeiraJA,ForresterGJ,HarveyEJ,AfthinosJ,KimGJ,etal.Singleincisionlaparoscopiccholecystectomyusingaflexibleendoscope.ArchSurg.2009Aug.144(8):7348.[Medline].

    17. GhazalAH,SorourMA,ElRiwiniM,ElBahrawyH.Singlesteptreatmentofgallbladderandbileductstones:acombinedendoscopiclaparoscopictechnique.IntJSurg.2009Aug.7(4):33846.[Medline].

    18. SchirmerBD,WintersKL,EdlichRF.Cholelithiasisandcholecystitis.JLongTermEffMedImplants.2005.15(3):32938.[Medline].

    19. [Guideline]OverbyDW,ApelgrenKN,RichardsonW,FanelliR.SAGESguidelinesfortheclinicalapplicationoflaparoscopicbiliarytractsurgery.SurgEndosc.2010Oct.24(10):236886.[Medline].[FullText].

    20. DanDV,HarnananD,MaharajR,SeetahalS,SinghY,NaraynsinghV.Laparoscopiccholecystectomy:analysisof619consecutivecasesinaCaribbeansetting.JNatlMedAssoc.2009Apr.101(4):35560.[Medline].

    21. GurusamyK,SahaySJ,BurroughsAK,DavidsonBR.Systematicreviewandmetaanalysisofintraoperativeversuspreoperativeendoscopicsphincterotomyinpatientswithgallbladderandsuspectedcommonbileductstones.BrJSurg.2011Jul.98(7):90816.[Medline].

    22. BeharJ,CorazziariE,GuelrudM,HoganW,ShermanS,ToouliJ.Functionalgallbladderandsphincterofoddidisorders.Gastroenterology.2006Apr.130(5):1498509.[Medline].

    23. AnderloniA,BallarM,PagliaruloM,ConteD,GaleazziM,OrselloM,etal.Prospectiveevaluationofearlyendoscopicultrasonographyfortriageinsuspectedcholedocholithiasis:Resultsfromalargesinglecentreseries.DigLiverDis.2013Dec28.[Medline].

    24. ReutersHealth.Endoscopicultrasoundagoodfirststepwhengallstonesaresuspected.MedscapeMedicalNews.January10,2014.Availableathttp://www.medscape.com/viewarticle/819024.Accessed:January20,2014.